← Open Payments lookup

MING LIN: Open Payments

NPI 1912144288 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$389 in 16 payments from 7 companies in 2025. Trend: 2023 $689 · 2024 $908 · 2025 $389

Food & beverage: $389
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.5$140
BridgeBio Pharma, Inc.2$48
ABBVIE INC.2$46
AstraZeneca Pharmaceuticals LP2$45
RECORDATI_RARE_DISEASES_INC.2$40
E.R. Squibb & Sons, L.L.C.2$40
Mallinckrodt Hospital Products Inc.1$31

Products named: JARDIANCE, Attruby, AVYCAZ, LOKELMA, ISTURISA, TERLIVAZ, ELIQUIS, CAMZYOS.

Industry payments across NY — which companies pay providers there.